Cancer Genomics for Oncologists: Cancer Risk and Management of BRCA1 and BRCA2 Carriers

被引：0
|
作者：
Angela George
机构：
[1] Royal Marsden NHS Foundation Trust,Gynae Oncology Unit and Cancer Genetics Unit, The Institute of Cancer Research
[2] The Institute of Cancer Research,undefined
[3] Royal Marsden NHS Foundation Trust,undefined
来源：
Current Genetic Medicine Reports | 2019年 / 7卷
关键词：
Cancer predisposition genes; BRCA; Homologous recombination deficiency; Risk-reducing; High-risk screening; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：116 / 123
页数：7
相关论文
共 50 条
  • [31] Cancer risk-modifying factors in BRCA1 or BRCA2 mutation carriers
    Rebbeck, TR
    FAMILIAL CANCER AND PREVENTION: MOLECULAR EPIDEMIOLOGY - A NEW STRATEGY TOWARD CANCER CONTROL, 1999, : 413 - 418
  • [32] Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Kleeberg, UR
    STRAHLENTHERAPIE UND ONKOLOGIE, 2003, 179 (10) : 718 - 719
  • [33] Oral contraceptives and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Jane C. Figueiredo
    Robert W. Haile
    Jonine L. Bernstein
    Current Breast Cancer Reports, 2009, 1 (3) : 139 - 147
  • [34] Weighing Options for Cancer Risk Reduction in Carriers of BRCA1 and BRCA2 Mutations
    Stadler, Zsofia K.
    Kauff, Noah D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) : 189 - 191
  • [35] Plasma osteoprotegerin and breast cancer risk in BRCA1 and BRCA2 mutation carriers
    Oden, Lovisa
    Akbari, Mohammad
    Zaman, Tasnim
    Singer, Christian F.
    Sun, Ping
    Narod, Steven A.
    Salmena, Leonardo
    Kotsopoulos, Joanne
    ONCOTARGET, 2016, 7 (52) : 86687 - 86694
  • [36] Weight Gain and the Risk of Ovarian Cancer in BRCA1 and BRCA2 Mutation Carriers
    Kim, Shana J.
    Lubinski, Jan
    Huzarski, Tomasz
    Moller, Pal
    Armel, Susan
    Karlan, Beth Y.
    Senter, Leigha
    Eisen, Andrea
    Foulkes, William D.
    Singer, Christian F.
    Tung, Nadine
    Bordeleau, Louise
    Neuhausen, Susan L.
    Olopade, Olufunmilayo, I
    Eng, Charis
    Weitzel, Jeffrey N.
    Fruscio, Robert
    Narod, Steven A.
    Kotsopoulos, Joanne
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (11) : 2038 - 2043
  • [37] Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Narod, SA
    Dubé, MP
    Klijn, J
    Lubinski, J
    Lynch, HT
    Ghadirian, P
    Provencher, D
    Heimdal, K
    Moller, P
    Robson, M
    Offit, K
    Isaacs, C
    Weber, B
    Friedman, E
    Gershoni-Baruch, R
    Rennert, G
    Pasini, B
    Wagner, T
    Daly, M
    Garber, JE
    Neuhausen, SL
    Ainsworth, P
    Olsson, H
    Evans, G
    Osborne, M
    Couch, F
    Foulkes, WD
    Warner, E
    Kim-Sing, C
    Olopade, O
    Tung, N
    Saal, HM
    Weitzel, J
    Merajver, S
    Gauthier-Villars, M
    Jernstrom, H
    Sun, P
    Brunet, JS
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (23): : 1773 - 1779
  • [38] Breast cancer risk among male BRCA1 and BRCA2 mutation carriers
    Tai, Yu Chuan
    Domchek, Susan
    Parmigiani, Giovanni
    Chen, Sining
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (23) : 1811 - 1814
  • [39] Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
    Joanne Kotsopoulos
    Jan Lubinski
    Henry T. Lynch
    Susan L. Neuhausen
    Parviz Ghadirian
    Claudine Isaacs
    Barbara Weber
    Charmaine Kim-Sing
    William D. Foulkes
    Ruth Gershoni-Baruch
    Peter Ainsworth
    Eitan Friedman
    Mary Daly
    Judy E. Garber
    Beth Karlan
    Olufunmilayo I. Olopade
    Nadine Tung
    Howard M. Saal
    Andrea Eisen
    Michael Osborne
    Hakan Olsson
    Dawna Gilchrist
    Ping Sun
    Steven A. Narod
    Cancer Causes & Control, 2005, 16 : 667 - 674
  • [40] Oral Contraceptives and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
    Figueiredo, Jane C.
    Haile, Robert W.
    Bernstein, Jonine L.
    CURRENT BREAST CANCER REPORTS, 2009, 1 (03) : 139 - 147
12345